Novo Nordisk’s obesity-fighting drugs are fattening Denmark’s economy while shrinking other sectors

Novo Nordisk’s blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities worldwide — all while adding great heft to Denmark’s economy.

Novo Nordisk now has a market cap of $600 billion, injecting a welcome dose of wealth into the Baltic nation while creating thousands of new jobs, bolstering national pension plans and keeping mortgage rates low.

RandyMarsh

Article URL : https://www.cbsnews.com/news/novo-nordisk-denmark-impact-60-minutes/